FlemingDM, CrombieDL. Prevalence of asthma and hay fever in England and Wales. Br Med J1987;294:279–283.
2.
SlyRM. Increases in death from asthma. Ann Allergy1984;53:20–25.
3.
BenatarSF. Fatal asthma. N Engl J Med1986;314:423–429.
4.
BarnesPJ. A new approach to the treatment of asthma. N Engl J Med1989;321:1517–1527.
5.
BeasleyR, RocheWR, RobertsJA, HolgateST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis1989;139:806–817.
6.
De MonchyJG, KauffmanHF, VengeP, . Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis1985;131:373–376.
7.
ChungKF. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax1986;41:657–662.
8.
FrigasE, GleichGJ. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol1986;77:527–537.
9.
YukawaT, ChanezP, DentG, . Bronchodilator agents do not inhibit oxygen-free radical release from guinea-pig eosinophils (abstract). Am Rev Respir Dis1988;137(4, Part 2):27.
10.
YukawaT, KroegelC, ChanezP, . Effect of theophylline and adenosine on eosinophil function. Am Rev Respir Dis1989;140:327–333.
11.
YukawaT, DentG, KroegelC, EvansP, BarnesPJ, ChungKF. Inhibition of guinea pig and human eosinophil function by corticosteroids in vitro. Thorax1989;44:883P.
12.
YamaguchiY, HayashiY, SugamaY, MiuraY, KasaharaT.Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL-5 as an eosinophil chemotactic factor. J Exp Med1988;167:1737–1742.
13.
ChurchMK, HiroiJ.Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol1987;90:421–429.
14.
JenkinsCR, WoolcockAJ. Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: A comparative study. Thorax1988;43:378–384.
15.
GonzalezJP, BrogdenR.Nedocromil sodium: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease. Drugs1987;34:560–577.
16.
LoftusBG, PriceJF. Long-term, placebo-controlled trial of ketotifen in the management of preschool children with asthma. J Allergy Clin Immunol1987;79:350–355.
17.
MullarkeyMF, BlumensteinBA, AndradeWP, BaileyGA, OlasonL, WetzelCE. Methotrexate in the treatment of corticosteroid-dependent asthma: A double-blind crossover study. N Engl J Med1988;318:603–607.
18.
KlaustermeyerWB, NoritakeDW, KwongFK. Chrysotherapy in the treatment of corticosteroid-dependent asthma. J Allergy Clin Immunol1987;79:720–725.
19.
SzeflerSJ, RoseJQ, EllisEF, SpectorSL, GreenAW, JuskoWJ. The effect of troleandomycin on methylprednisolone elimination. J Allergy Clin Immunol1988;66:447–451.
20.
BeynonHLC, GarbettHD, BarnesPJ. Severe premenstrual exacerbations of asthma: Effect of intramuscular progesterone. Lancet1988;2:370–372.
21.
ErjefaltI, PerssonCG. Anti-asthma drugs attenuate inflammatory leakage of plasma into airway lumen. Acta Physiol Scand1986;128:653–654.
22.
LofdahlC-G, SvedmyrN.Inhaled formoterol, a new beta2-adrenoceptor agonist, compared to salbutamol in asthmatic patients (abstract). Am Rev Respir Dis1988;137(4, Part 2):330.
23.
UllmanLA, SvedmyrN.Inhaled salmeterol, a new beta-adrenoceptor agonist produces sustained bronchodilation in asthmatic patients without causing tachyphylaxis (abstract). Am Rev Respir Dis1988;137(4, Part 2):32.
RebuckAS, ChapmanKR, AbboudR, . Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med1987;82:59–64.
26.
MorrisonJFJ, PearsonSB. Type I muscarinic receptors in asthma (abstract). Am Rev Respir Dis1988;137(4, Part 2):197.
27.
BrittonJR, HanleySP, TattersfieldAE. The effect of an oral leukotriene D4 antagonist L-649, 923 on the response to inhaled antigen in asthma. J Allergy Clin Immunol1987;79:811–821.
28.
FleischJH, CloudML, MarshallWS. A brief review of preclinical and clinical studies with LY 171883, and some comments on newer cysteinyl leukotriene receptor antagonists. Ann NY Acad Sci1988;524:356–368.
BeasleyR, RaffertyP, HarrisA, HolgateS.Inhibition of allergen induced immediate bronchoconstriction by the thromboxane receptor antagonist GR 32191 (abstract). Am Rev Respir Dis1988;137(4, Part 2):29.
31.
CussFM, DixonCMS, BarnesPJ. Effect of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet1986;2:189–192.
32.
BarnesPJ. Neural control of human airways in health and disease. Am Rev Respir Dis1986;134:1289–1314.
33.
RobertsonDW, SteinbergMI. Potassium channel openers: New biological probes. Ann Rev Med Chem1989;24:91–100.
